Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

The Effect of Hwangryunhaedok-tang and its Major Component Coptidis Rhizoma, Berberine on Nicotine Addiction in Rats

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2008, v.29 no.4, pp.55-67



  • Downloaded
  • Viewed

Abstract

Objectives: The purpose of this study was to investigate the effect of Hwangryunhaedok-tang, its major component Coptidis Rhizoma, and the major component of Coptidis Rhizoma, berberine, on the expression of behavioral sensitization induced by the repeated administration of nicotine. Methods:Experimental ratswere divided into 3 groups and each group treated with saline, nicotine, and Hwangryunhaedok-tang. Experiments were performed on 4 further groups, each group treated with saline, nicotine, Coptidis Rhizoma, and berberine. To obtain rats addicted todrugs, nicotine was injected repeatedly. After 3 days of withdrawal phase, on the 11th day, rats were re-exposed to nicotine and thus able to induce the expression of the activity sensitization phenomenon successfully. To examine the change of c-Fos in the brain of experimental rats with the nicotine-induced activity sensitization, their neurological activation rate was assessed by c-Fos staining with Fos-like immunihistochemistry of the dopamine releasing area, the striatum and the nucleus accumbens. Results: The result demonstrate that Hwangryunhaedok-tang, its major component Coptidis Rhizoma and berberine,the major component of Coptidis Rhizoma, significantly reduced the walking activity rate in the drug addict models induced by nicotine administration, and Coptidis Rhizoma and its major component berberine reduce the marker of the neurological activation c-Fos, and thus revealed an effect of suppressing drug addiction. Conclusions: These results suggest the possibility of Hwangryunhaedok-tang, its major component Coptidis Rhizoma and the major component of Coptidis Rhizoma, berberine,as therapeutic for nicotine addiction.

keywords
Hwangryunhaedok-tang, Coptidis Rhizoma, berberine, nicotine, behavioral sensitization, c-Fos, addiction, Hwangryunhaedok-tang, Coptidis Rhizoma, berberine, nicotine, behavioral sensitization, c-Fos, addiction


Reference

1

1. 윤석준, 하범만, 이희영, 문영배. 우리나라 국민의 흡연으로 인한 단일건강수준 측정지표 측정연구. 고려대학교 건강증진기금사업지원단. 2003:14.

2

2. 신태용. 약물 오ㆍ남용. 서울:신일상사. 2004:385 -90,402-4,409-12.

3

3. 충청남도 교육청. 학교 흡연 실태와 흡연 예방교육의 방향. 2003:3.

4

4. 백영홍, 최봉규, 김재하, 김종근, 김경근, 임영채, 정규용, 국현, 고정태, 이서울. 약리학. 서울:신일상사. 2004:275-8,290-1.

5

5. 한국약학대학협의회 약물학분과회. 약물학. 서울:문성사. 1994:177-8.

6

6. Centers for Disease Control and prevention. Guidelines for school health programs to prevent tobacco use and addiction. Journal of School Health. 1994;64(9):353-63.

7

7. Goodman LS, Gilman A. The pharmacological basis of therapeutic. 7th ed. New York:Macmillan. 1985:198.

8

8. 서영민. 황금이 니코틴 중독에 미치는 효과. 동국대학교 대학원 석사학위논문. 2003:15-6.

9

9. 王燾. 外臺秘要方. 서울:大星文化社. 1992:47.

10

10. 鄭津牟. 中醫處方解說ㆍ臨床ㆍ應用. 서울:癸丑文化社. 1992:354-7.

11

11. 辛民敎. 臨床本草學. 서울:永林社. 1997:402-4.

12

12. 吳普. 神農本草經. 서울:醫聖堂. 2003:79-80.

13

13. 陸昌洙. 本草學. 서울:癸丑文化社. 1998:114-7.

14

14. 김호철. 한약약리학. 서울:집문당. 2001:134-7.

15

15. 이정현. 접촉성 피부염에서 황련, 황련해독탕, 금은화가 림프구 활성에 미치는 영향. 동아대학교 대학원 박사학위논문. 2000:26-7.

16

16. 국윤범. 황련해독탕이 자발적 고혈압 백서의 혈압 및 신장기능에 미치는 영향. 원광대학교 대학원 박사학위논문. 2001:37.

17

17. 송대준. 황련해독탕이 緬羊赤血球에 대한 면역반응에 미치는 영향. 원광대학교논문집. 1984;(2) :195-206.(648)

18

18. 차재영, 김대진, 김석환, 김영길, 조영수. 실험적 중성지질 축적 HepG2세포에 미치는 황련해독탕의 약리적 효과. 한국식품영양학회지. 2003;32 (4):586-90.

19

19. 채윤병, 이봄비, 권영규, 함대현, 심인섭, 이혜정. 니코틴 중독에 대한 족삼리 전침자극 및 황련의 작용기전. 동의병리학회지. 2002;16(4):756-63.

20

20. 許浚. 東醫寶鑑. 서울:여강출판사. 1994:1401.

21

21. 보건복지부. 흡연으로 인한 직ㆍ간접 피해에 대한 실태조사 및 평가연구. 공주대학교. 2001.

22

22. Balfour DJK, Fagerstrom KO. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Phar- macol Ther. 1996;72:51-81.

23

23. Kosten TR, Hollister LE. Drug of abuse:Katzung BG. Katzung’s Clinical Pharmacology. 8th ed. New York:Apleton & Lange Publishing Co. 2000:532-47.

24

24. 임정규. 약물치료의 기초와 임상. 서울:고려의학. 1990:567-8.

25

25. 전국의과대학교수. 임상 약리학. 서울:대한의학서적. 2002:107-8.

26

26. Karan LD, Rosecrans JA. Addictive capacity of nicotine. Piasecki M, Newhouse PA. Nicotine in Psychiatry Psychopathology and emerging thera- peutics. Washington DC: American Psychiatric Press Inc. 2000:83-110.

27

27. Hughes JR. Tobacco withdrawal in self-quitters. Journal of Consulting and Clinical Psychology. 1992 Oct;60(5):689-97.

28

28. 박현상, 오귀분, 최영철, 김규한, 조동영, 유병연. 청소년 흡연실태 및 약물남용 일탈행위와의 관련성. 대한가정의학회지. 1999;20:387.

29

29. 의과대학 교수편역. 임상 약리학. 7판. 서울:한우리. 2000:589.

30

30. 葛洪. 肘後備急方. 서울:醫聖堂. 1993:32.

31

31. 張介賓. 國譯 景岳全書 第6冊. 서울:一中社. 1992 :474.

32

32. 權寧斗. 欽定四庫全書 子部五 醫家類. 서울:大星出版社. 1995;12:777.

33

33. 王士雄. 溫熱經緯. 北京:學苑出版社. 1997:160.

34

34. 許濟群, 王綿之. 中醫方劑學. 서울:陰陽脈診出版社. 1991:172-3.

35

35. 梁頌名. 中藥方劑學. 廣東省:廣東科技出版社. 1991 :186-7.

36

36. 游士勳, 張錦淸. 實用中醫方劑學. 台北市:樂群出版社. 1983:75-8.

37

37. 李飛. 方劑學. 北京市:人民衛生出版社. 2002:523 -30.

38

38. 金相贊 外 12人. 方劑學. 서울:永林社. 1999:180 -1.

39

39. 임종필. 본초생약학. 서울:신일상사. 2003:106-8.

40

40. 李時珍. 本草綱目. 서울:醫聖堂. 1993:771-9.

41

41. 생약학 연구회. 현대 생약학. 서울:학창사. 1994: 179,421.

42

42. 육창수, 김성만. 한약의 약리 성분 임상응용. 서울:계축문화사. 1982:406-9.

43

43. Creasey WA. Biochemical effect of berberine. Biochemical pharmacology. 1979 Apr 1;28(7): 1081-4.

44

44. 王冰. 新編黃帝內經素問. 서울:大星文化社. 1994 :300.

45

45. Robinson TE, Baker TB. Enduring changes in brain and behavior produced by chronic amphe- tamine administration a review and evalution of animal model of amphetamine psychosis. Brain Research Reviews. 1986 Jun; 11(2):157-98.

46

46. Panagis G, Nisell M, Nomikos GG, Chergui K, Svensson TH. Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rats. Brain Res. 1996 Aug;730(1-2):133-42.

47

47. Segal DS, Geyer MA, Schuckit MA. Stimulant- induced psychosis an evaluation of animal methods. Essays Neurochem Neuropharmacol. 1981;5:95-129.(649)

48

48. Reavill C, Stolerman IP. Locomotor activity in rats after administration of nicotine agonists intracerebrally. Br J Pharmacol, 1990 Feb;99(2) :273-78.

49

49. Vale AL, Balfour DJK. Studies on the role of brain dopamine system in the psychostimulant response to nicotine. Br J Pharmacol. 1988;94 :373.

50

50. Mathieu Kia AM, Pages C, Besson MJ. Inducibility of c-Fos protein in visuo-motor system and limbic structures after acute and repeated administration of nicotine in the ra. Synapse. 1998 Aug;29(4):343-54.

51

51. Kiba H, Jayaraman A. Nicotine induced c-fos expression in the striatum is mediated mostly by dopamine D1 receptor and is dependent on NMDA stimulation. Brain Research Molecular Brain Research. 1994 Apr;23(1-2):1-13.

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine